| Primary |
| Drug Use For Unknown Indication |
36.7% |
| Product Used For Unknown Indication |
30.6% |
| Pneumonia |
4.4% |
| Lower Respiratory Tract Infection |
4.0% |
| Infection |
3.1% |
| Acne |
2.6% |
| Bronchitis |
2.1% |
| Cellulitis |
1.7% |
| Pneumonia Mycoplasmal |
1.7% |
| Hypertension |
1.5% |
| Rosacea |
1.5% |
| Upper Respiratory Tract Infection |
1.2% |
| Rheumatoid Arthritis |
1.2% |
| Bacterial Infection |
1.1% |
| Drug Exposure During Pregnancy |
1.1% |
| Pain |
1.1% |
| Prophylaxis |
1.1% |
| Sinusitis |
1.1% |
| Foetal Exposure During Pregnancy |
1.0% |
| Antibiotic Prophylaxis |
1.0% |
|
| Vomiting |
15.2% |
| Rash |
13.7% |
| Urticaria |
11.0% |
| Drug Hypersensitivity |
10.0% |
| Nausea |
4.9% |
| Ototoxicity |
4.7% |
| Hypersensitivity |
4.4% |
| Abdominal Pain Upper |
3.7% |
| Abdominal Discomfort |
3.2% |
| Rhabdomyolysis |
3.2% |
| Swelling Face |
3.2% |
| Stevens-johnson Syndrome |
2.9% |
| Dyspnoea |
2.7% |
| Throat Tightness |
2.7% |
| Wheezing |
2.7% |
| Diarrhoea |
2.5% |
| Drug Ineffective |
2.5% |
| Tubulointerstitial Nephritis |
2.5% |
| Abdominal Pain |
2.2% |
| Pancreatitis Acute |
2.2% |
|
| Secondary |
| Product Used For Unknown Indication |
43.1% |
| Drug Use For Unknown Indication |
12.1% |
| Pneumonia |
7.7% |
| Hypertension |
4.9% |
| Cellulitis |
3.0% |
| Lower Respiratory Tract Infection |
3.0% |
| Infection |
3.0% |
| Rosacea |
2.8% |
| Bronchitis |
2.7% |
| Nosocomial Infection |
2.4% |
| Pain |
2.0% |
| Premature Rupture Of Membranes |
1.8% |
| Chalazion |
1.6% |
| Pyrexia |
1.6% |
| Upper Respiratory Tract Infection |
1.6% |
| Cough |
1.5% |
| Pneumonia Mycoplasmal |
1.3% |
| Psoas Abscess |
1.3% |
| Acne |
1.2% |
| Sepsis |
1.2% |
|
| Drug Hypersensitivity |
33.0% |
| Vomiting |
9.3% |
| Rhabdomyolysis |
8.9% |
| Toxic Epidermal Necrolysis |
5.4% |
| Tremor |
4.1% |
| Rash |
3.7% |
| Sepsis |
3.5% |
| Nausea |
3.3% |
| Vision Blurred |
3.1% |
| Weight Decreased |
3.1% |
| Urticaria |
2.9% |
| Stevens-johnson Syndrome |
2.5% |
| International Normalised Ratio Increased |
2.3% |
| Premature Baby |
2.3% |
| Respiratory Disorder |
2.3% |
| Oligohydramnios |
2.1% |
| Somnolence |
2.1% |
| Stillbirth |
2.1% |
| Vestibular Disorder |
2.1% |
| Clostridium Test Positive |
1.9% |
|
| Concomitant |
| Product Used For Unknown Indication |
35.1% |
| Drug Use For Unknown Indication |
14.3% |
| Acne |
11.7% |
| Hypertension |
4.7% |
| Pain |
3.5% |
| Depression |
2.9% |
| Asthma |
2.9% |
| Infection |
2.7% |
| Prophylaxis |
2.6% |
| Multiple Myeloma |
2.6% |
| Rheumatoid Arthritis |
2.3% |
| Osteoporosis |
2.0% |
| Sepsis |
1.8% |
| Gastrooesophageal Reflux Disease |
1.7% |
| Bronchitis |
1.7% |
| Crohn's Disease |
1.6% |
| Constipation |
1.6% |
| Contraception |
1.5% |
| Anxiety |
1.4% |
| Pneumonia |
1.4% |
|
| Weight Decreased |
14.8% |
| Vomiting |
13.3% |
| Weight Increased |
8.6% |
| Pneumonia |
4.9% |
| Thrombocytopenia |
4.8% |
| Urinary Tract Infection |
4.8% |
| White Blood Cell Count Increased |
4.8% |
| Pulmonary Embolism |
4.6% |
| Toxic Epidermal Necrolysis |
4.0% |
| Vision Blurred |
4.0% |
| Rash |
3.8% |
| Rhabdomyolysis |
3.5% |
| Wheezing |
3.5% |
| Transient Ischaemic Attack |
3.3% |
| Tinnitus |
3.1% |
| Death |
2.9% |
| Sepsis |
2.9% |
| Vitamin B12 Deficiency |
2.9% |
| Pain |
2.7% |
| Viral Infection |
2.7% |
|
| Interacting |
| Drug Use For Unknown Indication |
19.1% |
| Periorbital Cellulitis |
12.3% |
| Lower Respiratory Tract Infection |
8.0% |
| Breast Cancer Metastatic |
6.8% |
| Product Used For Unknown Indication |
6.8% |
| Prophylaxis |
6.2% |
| Chest Pain |
5.5% |
| Calcium Deficiency |
3.7% |
| Constipation |
3.7% |
| Respiratory Tract Infection |
3.7% |
| Pulmonary Embolism |
3.4% |
| Suicide Attempt |
3.1% |
| Immunosuppression |
2.8% |
| Prophylaxis Of Nausea And Vomiting |
2.5% |
| Cellulitis |
2.2% |
| Nephrotic Syndrome |
2.2% |
| Pain |
2.2% |
| Parapsoriasis |
2.2% |
| Renal Transplant |
2.2% |
| Diuretic Therapy |
1.8% |
|
| Vomiting |
15.3% |
| Pyrexia |
11.1% |
| Pneumonia |
9.7% |
| Drug Interaction |
8.3% |
| International Normalised Ratio Increased |
5.6% |
| Malaise |
5.6% |
| Blood Urea Increased |
4.2% |
| Rash Papular |
4.2% |
| Urinary Tract Infection |
4.2% |
| Weight Increased |
4.2% |
| Confusional State |
2.8% |
| Electrocardiogram Qt Prolonged |
2.8% |
| Gastrointestinal Haemorrhage |
2.8% |
| Lethargy |
2.8% |
| Mania |
2.8% |
| Myalgia |
2.8% |
| Psychotic Disorder |
2.8% |
| Rhabdomyolysis |
2.8% |
| Toxicity To Various Agents |
2.8% |
| Viral Load Increased |
2.8% |
|
